Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Histamine H3 Receptor Antagonist DL77 Ameliorates MK801-Induced Memory Deficits in Rats
Nermin Eissa, Nadia Khan, Shreesh Ojha, et al.
Frontiers in Neuroscience (2018) Vol. 12
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Current Enlightenment About Etiology and Pharmacological Treatment of Autism Spectrum Disorder
Nermin Eissa, Mohammed Al‐Houqani, Adel Sadeq, et al.
Frontiers in Neuroscience (2018) Vol. 12
Open Access | Times Cited: 236
Role of Neuroinflammation in Autism Spectrum Disorder and the Emergence of Brain Histaminergic System. Lessons Also for BPSD?
Nermin Eissa, Adel Sadeq, Astrid Sasse, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 76
The histamine H3R antagonist DL77 attenuates autistic behaviors in a prenatal valproic acid-induced mouse model of autism
Nermin Eissa, Petrilla Jayaprakash, Sheikh Azimullah, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 71
Exendin-4 attenuates brain mitochondrial toxicity through PI3K/Akt-dependent pathway in amyloid beta (1–42)-induced cognitive deficit rats
Debapriya Garabadu, Jaya Verma
Neurochemistry International (2019) Vol. 128, pp. 39-49
Closed Access | Times Cited: 56
Brain histamine modulates recognition memory: possible implications in major cognitive disorders
Gustavo Provensi, Alessia Costa, Iván Izquierdo, et al.
British Journal of Pharmacology (2018) Vol. 177, Iss. 3, pp. 539-556
Open Access | Times Cited: 56
Revisiting Preclinical Observations of Several Histamine H3 Receptor Antagonists/Inverse Agonists in Cognitive Impairment, Anxiety, Depression, and Sleep–Wake Cycle Disorder
Mera Alhusaini, Nermin Eissa, Ali Saad, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 26
An Expanded Narrative Review of Neurotransmitters on Alzheimer’s Disease: The Role of Therapeutic Interventions on Neurotransmission
Enes Akyüz, Alina Arulsamy, Feyza Şule Aslan, et al.
Molecular Neurobiology (2024)
Open Access | Times Cited: 5
Multi-target-directed-ligands acting as enzyme inhibitors and receptor ligands
Diego A. Rodríguez‐Soacha, Matthias Scheiner, Michael Decker
European Journal of Medicinal Chemistry (2019) Vol. 180, pp. 690-706
Closed Access | Times Cited: 36
Enigmatic Histamine Receptor H4 for Potential Treatment of Multiple Inflammatory, Autoimmune, and Related Diseases
Pakhuri Mehta, Przemysław Miszta, Przemysław Rzodkiewicz, et al.
Life (2020) Vol. 10, Iss. 4, pp. 50-50
Open Access | Times Cited: 30
Antagonism of Histamine H3 receptors Alleviates Pentylenetetrazole-Induced Kindling and Associated Memory Deficits by Mitigating Oxidative Stress, Central Neurotransmitters, and c-Fos Protein Expression in Rats
Alaa Alachkar, Sheikh Azimullah, Mohamed Lotfy, et al.
Molecules (2020) Vol. 25, Iss. 7, pp. 1575-1575
Open Access | Times Cited: 28
Histamine H3 receptor antagonist, ciproxifan, alleviates cognition and synaptic plasticity alterations in a valproic acid-induced animal model of autism
Farahnaz Taheri, Khadijeh Esmaeilpour, Gholamreza Sepehri, et al.
Psychopharmacology (2022) Vol. 239, Iss. 8, pp. 2673-2693
Closed Access | Times Cited: 18
Rational design of new multitarget histamine H3 receptor ligands as potential candidates for treatment of Alzheimer’s disease
Dorota Łażewska, Marek Bajda, Maria Kaleta, et al.
European Journal of Medicinal Chemistry (2020) Vol. 207, pp. 112743-112743
Closed Access | Times Cited: 24
Curcumin Potentiates α7 Nicotinic Acetylcholine Receptors and Alleviates Autistic-Like Social Deficits and Brain Oxidative Stress Status in Mice
Petrilla Jayaprakash, Dmytro Isaev, Waheed Shabbir, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7251-7251
Open Access | Times Cited: 23
Amelioration of cognition impairments in the valproic acid-induced animal model of autism by ciproxifan, a histamine H3-receptor antagonist
Farahnaz Taheri, Khadijeh Esmaeilpour, Gholamreza Sepehri, et al.
Behavioural Pharmacology (2023) Vol. 34, Iss. 4, pp. 179-196
Closed Access | Times Cited: 8
Histamine H3 Receptor Antagonist Enhances Neurogenesis and Improves Chronic Cerebral Hypoperfusion-Induced Cognitive Impairments
Na Wang, Jing Ma, Jing Liu, et al.
Frontiers in Pharmacology (2020) Vol. 10
Open Access | Times Cited: 20
The Potent and Selective Histamine H3 Receptor Antagonist E169 Counteracts Cognitive Deficits and Mitigates Disturbances in the PI3K/AKT/GSK-3β Signaling Pathway in MK801-Induced Amnesia in Mice
Sabna Abdalla, Nermin Eissa, Petrilla Jayaprakash, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12719-12719
Open Access | Times Cited: 5
4-tert-Pentylphenoxyalkyl derivatives – Histamine H3 receptor ligands and monoamine oxidase B inhibitors
Dorota Łażewska, Agnieszka Olejarz‐Maciej, Maria Kaleta, et al.
Bioorganic & Medicinal Chemistry Letters (2018) Vol. 28, Iss. 23-24, pp. 3596-3600
Closed Access | Times Cited: 15
<p>Histamine H3 receptor antagonist E177 attenuates amnesia induced by dizocilpine without modulation of anxiety-like behaviors in rats</p>
Alaa Alachkar, Nadia Khan, Dorota Łażewska, et al.
Neuropsychiatric Disease and Treatment (2019) Vol. Volume 15, pp. 531-542
Open Access | Times Cited: 15
Simultaneous Antagonism at H3R/D2R/D3R Reduces Autism-like Self-Grooming and Aggressive Behaviors by Mitigating MAPK Activation in Mice
Nermin Eissa, M. Awad, Shilu Deepa Thomas, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 526-526
Open Access | Times Cited: 8
Targeting Histamine and Histamine Receptors for Memory Regulation: An Emotional Perspective
Zhuowen Fang, Jiahui Chen, Yanrong Zheng, et al.
Current Neuropharmacology (2024) Vol. 22, Iss. 11, pp. 1846-1869
Open Access | Times Cited: 1
Alleviation of Autophagic Deficits and Neuroinflammation by Histamine H3 Receptor Antagonist E159 Ameliorates Autism-Related Behaviors in BTBR Mice
Shilu Deepa Thomas, Petrilla Jayaprakash, Nurfirzana Z. H. J. Marwan, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 10, pp. 1293-1293
Open Access | Times Cited: 1
Scopolamine and MK-801 impair recognition memory in a new spontaneous object exploration task in monkeys
André W.C. Oliveira, Jéssica V.N. Pacheco, Clara S. Costa, et al.
Pharmacology Biochemistry and Behavior (2021) Vol. 211, pp. 173300-173300
Closed Access | Times Cited: 9
Differential contribution of H3R antagonism by LINS01 compounds on memory, anxiety-like behaviour and spontaneous locomotor activity in healthy rats
Andressa Gabriela Soliani, Silvia Megumi Kubota, Michelle Fidelis Corrêa, et al.
Behavioural Brain Research (2019) Vol. 377, pp. 112230-112230
Closed Access | Times Cited: 9
Insights into the advances in therapeutic drugs for neuroinflammation-related diseases
B. Luo
International Journal of Neuroscience (2023), pp. 1-26
Closed Access | Times Cited: 3
Ameliorating effects of histamine H3 receptor antagonist E177 on acute pentylenetetrazole-induced memory impairments in rats
Alaa Alachkar, Mohamed Lotfy, Ernest Adeghate, et al.
Behavioural Brain Research (2021) Vol. 405, pp. 113193-113193
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top